Výsledky vyhledávání

Akademický článek

Anatomical and ultrasound navigation of intra joint injections

Autor: L. A. Knyazeva, N. Damjanov, L. I. Knyazeva, E. M. Khardikova, N. S. Meshcherina, M. A. Stepchenko, I. I. Goryainov

Publikováno v: Alʹmanah Kliničeskoj Mediciny, Vol 47, Iss 5, Pp 454-460 (2019)

Optimization of joint syndrome treatment methods, including those based on the intra- and periarticular drug administration and invasive diagnostic techniques, remains high on the agenda of modern clinical rheumatology. The implementation and quite w

Externí odkaz: https://doaj.org/article/078331a1e1ab42cf88f7de4ce3bc30fb

Zobrazit plný text záznamu

Akademický článek

Effect of golimumab on endothelial vasomotor function and arterial stiffness in ankylosing spondylitis

Autor: L. A. Knyazeva, N. Damjanov, L. I. Knyazeva, N. S. Meshcherina, I. I. Goryainov, M. A. Stepchenko, Ya. I. Bobyntsev, O. S. Rudakov

Publikováno v: Научно-практическая ревматология, Vol 57, Iss 3, Pp 312-317 (2019)

Objective: to evaluate the effect of golimumab (GLM) on endothelial vasomotor function and arterial stiffness in patients with ankylosing spondylitis (AS).Subjects and methods. A total of 42 patients with advanced-stage AS, who were older than 18 yea

Externí odkaz: https://doaj.org/article/a8d6e3d1cd944c719c40e58d666cfe41

Zobrazit plný text záznamu

Akademický článek

EFFECT OF GOLIMUMAB ON IMMUNOLOGICAL MARKERS FOR BONE METABOLISM AND ON ARTERIAL STIFFNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS

Autor: L. A. Knyazeva, N. Damjanov, L. I. Knyazeva, N. S. Meshcherina, I. I. Goryainov

Publikováno v: Научно-практическая ревматология, Vol 56, Iss 3, Pp 286-292 (2018)

Objective: to evaluate the effect of golimumab (GLM) on the receptor activator of NF-κB ligand (RANKL)/osteoprotegerin (OPG) transmembrane molecular system and arterial stiffness in patients with rheumatoid arthritis (RA).Subjects and methods. Thirt

Externí odkaz: https://doaj.org/article/80153d35ef734390a3ad97a53f8961cd

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

AB0889 Association Between Clinically Meaningful Improvements in Patient-Reported Outcomes and Stringent Measures of Disease Activity in Patients With Psoriatic Arthritis Treated With Upadacitinib Versus Placebo or Adalimumab: Results From a Phase 3 Trial

Autor: L. Gossec, N. Damjanov, S. Tsuji, A. Lertratanakul, R. Lippe, J. Patel, P. Zueger, K. De Vlam

Publikováno v: Annals of the Rheumatic Diseases. 81:1569-1570

BackgroundThe achievement of disease control has been shown to be associated with improved prognosis in PsA, though no single measure of low disease activity or remission is currently universally accepted. Patient-reported outcomes (PROs) have been w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::00e0f62a327de58e8b3bd34cb602c94a
https://doi.org/10.1136/annrheumdis-2022-eular.1371

Zobrazit plný text záznamu

POS0383 CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH SYSTEMIC SCLEROSIS SINE SCLERODERMA: DATA FROM THE INTERNATIONAL EUSTAR DATABASE

Autor: A. Lescoat, S. Huang, P. Carreira, E. Siegert, J. De Vries-Bouwstra, J. H. W. Distler, V. Smith, F. Del Galdo, B. Anic, N. Damjanov, S. Rednic, C. Ribi, D. Farge, A. M. Hoffmann-Vold, A. Gabrielli, O. Distler, D. Khanna, Y. Allanore

Publikováno v: Annals of the Rheumatic Diseases. 81:446.1-446

BackgroundLeRoy’s classification defines two main subsets of Systemic Sclerosis (SSc) based on the extent of skin fibrosis: limited cutaneous SSc (lcSSc) with skin thickening sparing the trunk and distal to the elbow and knees, and diffuse cutaneou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::471e02227505166377f5fb3591fb2b14
https://doi.org/10.1136/annrheumdis-2022-eular.3773

Zobrazit plný text záznamu

AB0350 ASSESSMENT OF REAL-LIFE PATIENT HANDLING EXPERIENCE OF AVT02 ADMINISTERED SUBCUTANEOUSLY VIA AUTOINJECTOR IN PATIENTS WITH MODERATE-TO-SEVERE ACTIVE RHEUMATOID ARTHRITIS: AN OPEN-LABEL, SINGLE-ARM CLINICAL TRIAL, THEN AN EXTENSION PHASE OF AVT02 ADMINISTERED WITH A PRE-FILLED SYRINGE (ALVOPAD-PEN)

Autor: N. Damjanov, H. Stroissnig, M. Steiger, J. Sobierska, E. Guenzi, H. Otto, A. Sattar, H. N. Haliduola, E. Edwald, F. Berti

Publikováno v: Annals of the Rheumatic Diseases. 81:1301.1-1301

BackgroundAVT02 is an investigational biosimilar to adalimumab. It is approved in Europe, Canada, and the UK. It is not approved by the US Food and Drug Administration (FDA).ObjectivesTo assess the real-life patient handling of an autoinjector (AI) i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::abebd1a25b80746c01abbbc1e8d6f389
https://doi.org/10.1136/annrheumdis-2022-eular.2407

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání